c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate. Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [629]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [178]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was not due to increased protein levels of GLS or c-Myc, which regulates GLS expression”
From Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma (2018) · cites this paper as Gao et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
From Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (2009) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [79]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citationTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationYates, J. R., Eng, J. K., McCormack, A. L., & Schieltz, D. (1995) · Analytical Chemistry · doi:10.1021/ac00104a020 · Cited by 1,253
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Cited by
Items 301–400 of 1,006
Metabolic changes in cancer: beyond the Warburg effect
Wu, W., & Zhao, S. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms104 · Cited by 173
Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth
Wang, K.-C., Garmire, L. X., Young, A., Nguyen, P., Trinh, A., Subramaniam, S., Wang, N., Shyy, J. Y., Li, Y.-S., & Chien, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914825107 · Cited by 172
A pathway map of glutamate metabolism
Yelamanchi, S. D., Jayaram, S., Thomas, J. K., Gundimeda, S., Khan, A. A., Singhal, A., Keshava Prasad, T. S., Pandey, A., Somani, B. L., & Gowda, H. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0315-5 · Cited by 172
The role of glutaminase in cancer
Masisi, B. K., El Ansari, R., Alfarsi, L., Rakha, E. A., Green, A. R., & Craze, M. L. (2020) · Histopathology · doi:10.1111/his.14014 · Cited by 170
Non-coding RNAs: the new central dogma of cancer biology
Saw, P. E., Xu, X., Chen, J., & Song, E.-W. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1700-9 · Cited by 171
Lampa, M., Arlt, H., He, T., Ospina, B., Reeves, J., Zhang, B., Murtie, J., Deng, G., Barberis, C., Hoffmann, D., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185092 · Cited by 170
Wang, Y.-Q., Wang, H.-L., Xu, J., Tan, J., Fu, L.-N., Wang, J.-L., Zou, T.-H., Sun, D.-F., Gao, Q.-Y., Chen, Y.-X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02951-4 · Cited by 167
Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism
Benej, M., Hong, X., Vibhute, S., Scott, S., Wu, J., Graves, E., Le, Q.-T., Koong, A. C., Giaccia, A. J., Yu, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808945115 · Cited by 168
Altered cancer metabolism in mechanisms of immunotherapy resistance
Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, E. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 170
Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells
Smith, B., Schafer, X. L., Ambeskovic, A., Spencer, C. M., Land, H., & Munger, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.045 · Cited by 170
Amino Acid Transporters and Glutamine Metabolism in Breast Cancer
Cha, Y., Kim, E.-S., & Koo, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030907 · Cited by 168
Oncogene-Directed Alterations in Cancer Cell Metabolism
Nagarajan, A., Malvi, P., & Wajapeyee, N. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.06.002 · Cited by 169
“MYC can also indirectly regulate metabolism via microRNAs (miRNAs) [15, 16].”
BackgroundFu, S., Li, Z., Xiao, L., Hu, W., Zhang, L., Xie, B., Zhou, Q., He, J., Qiu, Y., Wen, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.002 · Cited by 169
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169
CAO, M., SEIKE, M., SOENO, C., MIZUTANI, H., KITAMURA, K., MINEGISHI, Y., NORO, R., YOSHIMURA, A., CAI, L., & GEMMA, A. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1535 · Cited by 169
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
Chiaradonna, F., Ricciardiello, F., & Palorini, R. (2018) · Cells · doi:10.3390/cells7060053 · Cited by 168
Craig, V. J., Cogliatti, S. B., Imig, J., Renner, C., Neuenschwander, S., Rehrauer, H., Schlapbach, R., Dirnhofer, S., Tzankov, A., & Müller, A. (2011) · Blood · doi:10.1182/blood-2010-10-312231 · Cited by 166
Li, C., Zhang, G., Zhao, L., Ma, Z., & Chen, H. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0769-9 · Cited by 167
Rapid Analysis of Glycolytic and Oxidative Substrate Flux of Cancer Cells in a Microplate
Pike Winer, L. S., & Wu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109916 · Cited by 165
Transcription Factors in Cancer Development and Therapy
Vishnoi, K., Viswakarma, N., Rana, A., & Rana, B. (2020) · Cancers · doi:10.3390/cancers12082296 · Cited by 164
Ralph, S. J., Rodríguez-Enríquez, S., Neuzil, J., & Moreno-Sánchez, R. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.006 · Cited by 165
Kaadige, M. R., Looper, R. E., Kamalanaadhan, S., & Ayer, D. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901221106 · Cited by 162
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Ma, Z., & Vosseller, K. (2013) · Amino Acids · doi:10.1007/s00726-013-1543-8 · Cited by 162
Mitochondrial Metabolism and Cancer
Weinberg, F., & Chandel, N. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05039.x · Cited by 162
Targeting cancer metabolism – aiming at a tumour's sweet-spot
Jones, N. P., & Schulze, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.017 · Cited by 162
The Proline Regulatory Axis and Cancer
Phang, J. M., Liu, W., Hancock, C., & Christian, K. J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00060 · Cited by 161
Oncogenic regulation of tumor metabolic reprogramming
Tarrado-Castellarnau, M., de Atauri, P., & Cascante, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10911 · Cited by 161
Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer
Matés, J. M., Di Paola, F. J., Campos-Sandoval, J. A., Mazurek, S., & Márquez, J. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.012 · Cited by 162
α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer
Tran, T. Q., Hanse, E. A., Habowski, A. N., Li, H., Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Ooi, A. M., Liao, S. Y., Edwards, R. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0035-5 · Cited by 161
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
Schöckel, L., Glasauer, A., Basit, F., Bitschar, K., Truong, H., Erdmann, G., Algire, C., Hägebarth, A., Willems, P. H., Kopitz, C., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0138-0 · Cited by 161
Landscape of the mitochondrial Hsp90 metabolome in tumours
Chae, Y. C., Angelin, A., Lisanti, S., Kossenkov, A. V., Speicher, K. D., Wang, H., Powers, J. F., Tischler, A. S., Pacak, K., Fliedner, S., et al. (2013) · Nature Communications · doi:10.1038/ncomms3139 · Cited by 161
Glutamine homeostasis and mitochondrial dynamics
Matés, J. M., Segura, J. A., Campos-Sandoval, J. A., Lobo, C., Alonso, L., Alonso, F. J., & Márquez, J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.003 · Cited by 160
miR-23b* targets proline oxidase, a novel tumor suppressor protein in renal cancer
Liu, W., Zabirnyk, O., Wang, H., Shiao, Y.-H., Nickerson, M. L., Khalil, S., Anderson, L. M., Perantoni, A. O., & Phang, J. M. (2010) · Oncogene · doi:10.1038/onc.2010.237 · Cited by 160
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma
Suzuki, S., Venkatesh, D., Kanda, H., Nakayama, A., Hosokawa, H., Lee, E., Miki, T., Stockwell, B. R., Yokote, K., Tanaka, T., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3914 · Cited by 159
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Zhang, H., Li, S., Wang, D., Liu, S. M., Xiao, T., Gu, W., Yang, H., Wang, H. Z., Yang, M., & Chen, P. (2024) · Biomarker Research · doi:10.1186/s40364-024-00646-1 · Cited by 214
Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor
DeLaBarre, B., Gross, S., Fang, C., Gao, Y., Jha, A., Jiang, F., Song J., J., Wei, W., & Hurov, J. B. (2011) · Biochemistry · doi:10.1021/bi201613d · Cited by 157
Mitochondrial Sirtuins and Their Relationships with Metabolic Disease and Cancer
Kumar, S., & Lombard, D. B. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6213 · Cited by 158
Targeting the Warburg effect via LDHA inhibition engages ATF 4 signaling for cancer cell survival
Pathria, G., Scott, D. A., Feng, Y., Sang Lee, J., Fujita, Y., Zhang, G., Sahu, A. D., Ruppin, E., Herlyn, M., Osterman, A. L., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899735 · Cited by 156
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. A. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159
Regulation of Glucose Metabolism – A Perspective From Cell Bioprocessing
Mulukutla, B. C., Yongky, A., Le, T. S., Mashek, D. G., & Hu, W. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.04.012 · Cited by 176
The differential role of reactive oxygen species in early and late stages of cancer
Assi, M. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00247.2017 · Cited by 158
To eat or not to eat — the metabolic flavor of ferroptosis
Gao, M., & Jiang, X. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.11.001 · Cited by 158
Tannir, N. M., Agarwal, N., Porta, C., Lawrence, N. J., Motzer, R. J., McGregor, B. A., Lee, R. J., Jain, R., Davis, N. B., Appleman, L. J., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.3511 · Cited by 168
Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer
Momcilovic, M., Bailey, S. T., Lee, J. T., Fishbein, M. C., Magyar, C., Braas, D., Graeber, T., Jackson, N. J., Czernin, J., Emberley, E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.061 · Cited by 157
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth
Aboud, O. A., Chen, C., Senapedis, W. T., Baloglu, E., Argueta, C. E., & Weiss, R. H. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0197 · Cited by 162
Significance of Lgr5+ve Cancer Stem Cells in the Colon and Rectum
Takahashi, H., Ishii, H., Nishida, N., Takemasa, I., Mizushima, T., Ikeda, M., Yokobori, T., Mimori, K., Yamamoto, H., Sekimoto, M., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1373-9 · Cited by 168
Nonsense-Mediated RNA Decay Regulation by Cellular Stress: Implications for Tumorigenesis
Gardner, L. B. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0502 · Cited by 155
Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism?
Erickson, J. W., & Cerione, R. A. (2010) · Oncotarget · doi:10.18632/oncotarget.208 · Cited by 155
MYC-induced reprogramming of glutamine catabolism supports optimal virus replication
Thai, M., Thaker, S. K., Feng, J., Du, Y., Hu, H., Ting Wu, T., Graeber, T. G., Braas, D., & Christofk, H. R. (2015) · Nature Communications · doi:10.1038/ncomms9873 · Cited by 155
The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
Ren, P., Yue, M., Xiao, D., Xiu, R., Gan, L., Liu, H., & Qing, G. (2015) · The Journal of Pathology · doi:10.1002/path.4429 · Cited by 154
PGC-1α supports glutamine metabolism in breast cancer
McGuirk, S., Gravel, S.-P., Deblois, G., Papadopoli, D. J., Faubert, B., Wegner, A., Hiller, K., Avizonis, D., Akavia, U. D., Jones, R. G., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-22 · Cited by 154
Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
Sunami, Y., Rebelo, A., & Kleeff, J. H. (2017) · Cancers · doi:10.3390/cancers10010003 · Cited by 167
Emadi, A., Jun, S. A., Tsukamoto, T., Fathi, A. T., Minden, M. D., & Dang, C. V. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.12.001 · Cited by 175
Self-citationIncreased glutamine catabolism mediates bone anabolism in response to WNT signaling
Karner, C. M., Esen, E., Okunade, A. L., Patterson, B. W., & Long, F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78470 · Cited by 151
Fang, X., Zhou, W., Wu, Q., Huang, Z., Shi, Y., Yang, K., Chen, C., Xie, Q., Mack, S. C., Wang, X., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151673 · Cited by 164
Therapeutic Strategies Impacting Cancer Cell Glutamine Metabolism
Lukey, M. J., Wilson, K. F., & Cerione, R. A. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.130 · Cited by 152
Mammalian MYC Proteins and Cancer
Tansey, W. P. (2014) · New Journal of Science · doi:10.1155/2014/757534 · Cited by 151
Gallipoli, P., Giotopoulos, G., Tzelepis, K., Costa, A. S. H., Vohra, S., Medina-Perez, P., Basheer, F., Marando, L., Di Lisio, L., Dias, J. M. L., et al. (2018) · Blood · doi:10.1182/blood-2017-12-820035 · Cited by 151
Mitochondria and Cancer: A Growing Role in Apoptosis, Cancer Cell Metabolism and Dedifferentiation
Scatena, R. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_13 · Cited by 163
Synthesis of Optically Pure 4-Fluoro-Glutamines as Potential Metabolic Imaging Agents for Tumors
Qu, W., Zha, Z., Ploessl, K., Lieberman, B. P., Zhu, L., Wise, D. R., B. Thompson, C., & Kung, H. F. (2011) · Journal of the American Chemical Society · doi:10.1021/ja109203d · Cited by 150
The regulation of cellular metabolism by tumor suppressor p53
Liang, Y., Liu, J., & Feng, Z. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-9 · Cited by 150
The miRNA: a small but powerful RNA for COVID-19
Zhang, S., Amahong, K., Sun, X., Lian, X., Liu, J., Sun, H., Lou, Y., Zhu, F., & Qiu, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab062 · Cited by 154
Koochekpour, S., Majumdar, S., Azabdaftari, G., Attwood, K. M., Scioneaux, R., Subramani, D., Manhardt, C. T., Lorusso, G. D., Willard, S. S., Thompson, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1308 · Cited by 160
Redox control of glutamine utilization in cancer
Alberghina, L., & Gaglio, D. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.513 · Cited by 147
Cancer Metabolism: Is Glutamine Sweeter than Glucose?
Lu, W., Pelicano, H., & Huang, P. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.017 · Cited by 146
Coppola, V., Maria, R. D., & Bonci, D. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0172 · Cited by 173
Cancer’s Fuel Choice: New Flavors for a Picky Eater
DeNicola, G. M., & Cantley, L. C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.018 · Cited by 146
Simon, J., Nuñez-García, M., Fernández-Tussy, P., Barbier-Torres, L., Fernández-Ramos, D., Gómez-Santos, B., Buqué, X., Lopitz-Otsoa, F., Goikoetxea-Usandizaga, N., Serrano-Macia, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.013 · Cited by 146
Li, J., Cheng, D., Zhu, M., Yu, H., Pan, Z., Liu, L., Qin, G., Pan, H., Yan, M., & Yao, M. (2018) · Theranostics · doi:10.7150/thno.29545 · Cited by 156
The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
Prochownik, E. V., & Wang, H. (2021) · Cells · doi:10.3390/cells10040762 · Cited by 142
Marie, S. K. N., & Oba‐Shinjo, S. M. (2011) · Clinics · doi:10.1590/s1807-59322011001300005 · Cited by 175
Alteration of the lipid profile in lymphomas induced by MYC overexpression
Eberlin, L. S., Gabay, M., Fan, A. C., Gouw, A. M., Tibshirani, R. J., Felsher, D. W., & Zare, R. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409778111 · Cited by 143
WNT Signaling: an Emerging Mediator of Cancer Cell Metabolism?
Sherwood, V. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00992-14 · Cited by 142
Control of mitochondrial activity by miRNAs
Li, P., Jiao, J., Gao, G., & Prabhakar, B. S. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24004 · Cited by 141
Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis
Nieminen, A. I., Eskelinen, V. M., Haikala, H. M., Tervonen, T. A., Yan, Y., Partanen, J. I., & Klefström, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208530110 · Cited by 141
Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer
Kim, S., Kim, D. H., Jung, W.-H., & Koo, J. S. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0398 · Cited by 141
von Eyß, B., Jaenicke, L. A., Kortlever, R. M., Royla, N., Wiese, K. E., Letschert, S., McDuffus, L., Sauer, M., Rosenwald, A., Evan, G. I., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.013 · Cited by 151
Kouidhi, S., Elgaaied, A. B., & Chouaib, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00270 · Cited by 138
El Ansari, R., Craze, M. L., Miligy, I., Diez-Rodriguez, M., Nolan, C. C., Ellis, I. O., Rakha, E. A., & Green, A. R. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0946-6 · Cited by 139
SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis
Greene, K. S., Lukey, M. J., Wang, X., Blank, B. S., Druso, J. E., Lin, M.-C. J., Stalnecker, C. A., Zhang, C., Abril, Y. L. N., Erickson, J. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911954116 · Cited by 140
Targeting c-Myc as a novel approach for hepatocellular carcinoma
Lin, C.-P., Liu, C.-R., Lee, C.-N., Chan, T., & Liu, H. E. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i1.16 · Cited by 158
Li, X., Liu, X., Xu, W., Zhou, P., Gao, P., Jiang, S., Lobie, P. E., & Zhu, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478560 · Cited by 137
Self-citationBui, T. V., & Mendell, J. T. (2010) · Genes & Cancer · doi:10.1177/1947601910377491 · Cited by 135
Self-citationLactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
McCleland, M. L., Adler, A. S., Deming, L., Cosino, E., Lee, L., Blackwood, E. M., Solon, M., Tao, J., Li, L., Shames, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2638 · Cited by 134
Metabolic flux rewiring in mammalian cell cultures
Young, J. D. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.04.016 · Cited by 136
Cancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 144
Self-citationThe Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context
Xing, F., Hu, Q., Qin, Y., Xu, J., Zhang, B., Yu, X., & Wang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.862743 · Cited by 154
Glutamine metabolism in breast cancer and possible therapeutic targets
Li, S., Zeng, H., Fan, J., Wang, X., Xu, C., Li, Y., Tu, J., Nephew, K. P., & Long, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115464 · Cited by 153
Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer
Zaman, M. S., Thamminana, S., Shahryari, V., Chiyomaru, T., Deng, G., Saini, S., Majid, S., Fukuhara, S., Chang, I., Arora, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050203 · Cited by 141
Regulation of nonsense-mediated mRNA decay: Implications for physiology and disease
Karam, R., Wengrod, J., Gardner, L. B., & Wilkinson, M. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.03.002 · Cited by 145
AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer
Priolo, C., Pyne, S., Rose, J., Regan, E. R., Zadra, G., Photopoulos, C., Cacciatore, S., Schultz, D., Scaglia, N., McDunn, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1490 · Cited by 134
The Roles of Mitochondrial SIRT4 in Cellular Metabolism
Min, Z., Gao, J., & Yu, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00783 · Cited by 148
Transcriptional and epigenetic regulation of human microRNAs
Wang, Z., Yao, H., Lin, S., Zhu, X., Shen, Z., Lü, G., Poon, W. S., Xie, D., Lin, M. C.-M., & Kung, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.12.006 · Cited by 147
Xiong, J., Du, Q., & Liang, Z. (2010) · Oncogene · doi:10.1038/onc.2010.241 · Cited by 145
Metabolic Reprogramming in Brain Tumors
Venneti, S., & Thompson, C. B. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044329 · Cited by 153
Current Understanding on the Metabolism of Neutrophils
Jeon, J., Hong, C.-W., Kim, E. Y., & Lee, J. M. (2020) · Immune Network · doi:10.4110/in.2020.20.e46 · Cited by 146
Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways
Mulukutla, B. C., Khan, S., Lange, A., & Hu, W.-S. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.06.005 · Cited by 132
Altered energy metabolism in cancer: A unique opportunity for therapeutic intervention
Zhang, Y., & Yang, J.-M. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.22958 · Cited by 132
Metadata
- Authors
- Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Teikyo University (JP)
- Corresponding author
- Gao, Ping
- Dang, Chi V.
- Venue
- Nature
- Published
- 2009-02-15
- Volume
- 458
- Issue
- 7239
- Pages
- 762-765
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2729443
- OpenAlex
- W2074873270
- Cited by
- 2,124
- References
- 30
- Citations by year
- 2026: 50 · 2025: 85 · 2024: 105 · 2023: 138 · 2022: 131 · 2021: 142 · 2020: 158 · 2019: 146 · 2018: 146 · 2017: 134 · 2016: 126 · 2015: 145 · 2014: 161 · 2013: 125 · 2012: 144
- FWCI
- 37.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Institutes of Health (n01hv28180-13-0-0)
- National Heart, Lung, and Blood Institute (N01 HV-28180, N01 HV028180, R01HL085434)
- National Cancer Institute (R01 CA57341, R01CA057341, R01CA120185, P50CA058236, R37CA051497, P50-CA58236, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- c-Myc, miR-23a, miR-23b, glutamine metabolism, glutaminolysis, microRNA regulation, cancer metabolism, Warburg effect, PC-3 cells, reactive oxygen species, glutathione synthesis
- MeSH terms
- Glutaminase, Glutamine, Humans, Mitochondria, Gene Expression Regulation, Enzymologic, Proto-Oncogene Proteins c-myc, 3' Untranslated Regions, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.